๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Partial rescreening for quality assurance in gynecological cytology

โœ Scribed by C. A. Faraker

Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
27 KB
Volume
16
Category
Article
ISSN
8755-1039

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Evaluation of the 10% rescreen of negati
Evaluation of the 10% rescreen of negative gynecologic smears as a quality assurance measure
โœ Sana O. Tabbara; Mary K. Sidawy ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 335 KB

The CLIA '88 regulations require the laboratory to review at least ## 10% of the gynecologic cases interpreted as negative that are examined by each cytotechnologist. The review must include negative cases selected at random and from patients identiJed as a high risk group. To evaluate the validity

Intralaboratory quality assurance in cer
Intralaboratory quality assurance in cervical/vaginal cytology: Evaluation of intercytologist diagnostic reproducibility
โœ Valeria Cocchi; Donata Carretti; Simonetta Fanti; Paola Baldazzi; Maria Teresa C ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 52 KB

Diagnostic reproducibility and accuracy in evaluating cervical/ vaginal smears were the focus of this study concerning intralaboratory quality control. A set of 120 cytological samples was evaluated by 15 cytopathologists whose experience ranged from 3-29 yr. The study report form was based on the 1

Peritoneal washing cytology is unnecessa
Peritoneal washing cytology is unnecessary in gynecologic surgery for benign diseases
โœ Sharifi, Sheida ;Ducatman, Barbara S. ;Wang, Helen H. ;Fraser, Jean L. ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 69 KB ๐Ÿ‘ 1 views

## BACKGROUND. The presence of tumor cells in peritoneal washing cytology specimens taken during surgery affects the staging of many gynecologic malignancies. Peritoneal washings are often collected routinely, even in cases of presumed benign disease. This study was designed to address whether eva

The quality assurance and quality contro
The quality assurance and quality control issues for sponsors on GCP compliance in Japan
โœ Kouichi Inoue; Saburo Hasebe ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 101 KB

Implementing and maintaining quality assurance (QA) and quality control (QC) systems for clinical trials is essential for sponsors to assure the integrity and reliability of clinical trials and the data obtained from clinical trials. The main points of the revised Good Clinical Practice (GCP) in Jap